Cargando…

649. The Clinical Significance of Sequence Type 17 of Vancomycin-Resistant Enterococcus faecium

BACKGROUND: Sequence type (ST) 17 of vancomycin-resistant Enterococcus faecium (VREF) is known to be associated with nosocomial isolates. However, there is no evidence of the effect of ST17 VREF on the patient`s clinical outcome. We conducted a retrospective cohort study to identify ST17 VREF would...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Si-Ho, Cho, Sun Young, Kim, Hye Mee, Oh, Suhyun, Jang, Sukbin, Mun, Seokjun, Huh, Kyungmin, Kang, Cheol-In, Peck, Kyong Ran, Chung, Doo Ryun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6255637/
http://dx.doi.org/10.1093/ofid/ofy210.656
_version_ 1783373988269916160
author Kim, Si-Ho
Cho, Sun Young
Kim, Hye Mee
Oh, Suhyun
Jang, Sukbin
Mun, Seokjun
Huh, Kyungmin
Kang, Cheol-In
Peck, Kyong Ran
Chung, Doo Ryun
author_facet Kim, Si-Ho
Cho, Sun Young
Kim, Hye Mee
Oh, Suhyun
Jang, Sukbin
Mun, Seokjun
Huh, Kyungmin
Kang, Cheol-In
Peck, Kyong Ran
Chung, Doo Ryun
author_sort Kim, Si-Ho
collection PubMed
description BACKGROUND: Sequence type (ST) 17 of vancomycin-resistant Enterococcus faecium (VREF) is known to be associated with nosocomial isolates. However, there is no evidence of the effect of ST17 VREF on the patient`s clinical outcome. We conducted a retrospective cohort study to identify ST17 VREF would contribute to developing subsequent bacteremia among VREF-colonized patients. METHODS: VREF-colonized patients and its non-repetitive rectal VREF isolates were collected between March 2014 and February 2015. Subsequent bacteremia event within 1 year after colonization was reviewed from electronic medical records. STs were identified by multi-locus sequence typing. Cohort was defined as VREF with ST17 or non-ST17. Multivariable cox regression model was used to adjust effect of ST17 for developing subsequent bacteremia. If available, pulsed field gel electrophoresis (PFGE) was conducted to compare similarity between rectal and blood VREF isolates. RESULTS: Fifty-two patients with ST17 and 169 patients with non-ST17 VREF carriage were included in each cohort. There were six cases and 10 cases of subsequent bacteremia in cohorts ST17 and non-ST17, and 1-year VREF bacteremia free rates were 85.9% and 90.2%, respectively. There was no significant difference of subsequent bacteremia (P = 0.257) in log-rank test. However, after adjusted in multivariable models, VREF ST 17 was associated with subsequent bacteremia (adjusted relative risk, 4.02; 95% CI, 1.32–12.29, P = 0.015). Of 16 patients who had developed to subsequent VREF bacteremia, 12 VREF blood isolates could be analyzed. Only six cases (50%) of rectal and blood isolates had identical ST, whereas all available ST17 VREF cases (four cases) had identical ST and PFGE pattern (Figures 1 and 2). Patients who had identical ST isolates had shorter time difference than those who had non-identical ST isolates (P = 0.041). CONCLUSION: In our study, ST17 VREF was risk factors of subsequent bacteremia and the strain that showed strong concordance between rectal and blood isolates. Further study is needed to improve clinical outcome of patients carrying VREF using genotype data of rectal VREF isolates. DISCLOSURES: All authors: No reported disclosures.
format Online
Article
Text
id pubmed-6255637
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-62556372018-11-28 649. The Clinical Significance of Sequence Type 17 of Vancomycin-Resistant Enterococcus faecium Kim, Si-Ho Cho, Sun Young Kim, Hye Mee Oh, Suhyun Jang, Sukbin Mun, Seokjun Huh, Kyungmin Kang, Cheol-In Peck, Kyong Ran Chung, Doo Ryun Open Forum Infect Dis Abstracts BACKGROUND: Sequence type (ST) 17 of vancomycin-resistant Enterococcus faecium (VREF) is known to be associated with nosocomial isolates. However, there is no evidence of the effect of ST17 VREF on the patient`s clinical outcome. We conducted a retrospective cohort study to identify ST17 VREF would contribute to developing subsequent bacteremia among VREF-colonized patients. METHODS: VREF-colonized patients and its non-repetitive rectal VREF isolates were collected between March 2014 and February 2015. Subsequent bacteremia event within 1 year after colonization was reviewed from electronic medical records. STs were identified by multi-locus sequence typing. Cohort was defined as VREF with ST17 or non-ST17. Multivariable cox regression model was used to adjust effect of ST17 for developing subsequent bacteremia. If available, pulsed field gel electrophoresis (PFGE) was conducted to compare similarity between rectal and blood VREF isolates. RESULTS: Fifty-two patients with ST17 and 169 patients with non-ST17 VREF carriage were included in each cohort. There were six cases and 10 cases of subsequent bacteremia in cohorts ST17 and non-ST17, and 1-year VREF bacteremia free rates were 85.9% and 90.2%, respectively. There was no significant difference of subsequent bacteremia (P = 0.257) in log-rank test. However, after adjusted in multivariable models, VREF ST 17 was associated with subsequent bacteremia (adjusted relative risk, 4.02; 95% CI, 1.32–12.29, P = 0.015). Of 16 patients who had developed to subsequent VREF bacteremia, 12 VREF blood isolates could be analyzed. Only six cases (50%) of rectal and blood isolates had identical ST, whereas all available ST17 VREF cases (four cases) had identical ST and PFGE pattern (Figures 1 and 2). Patients who had identical ST isolates had shorter time difference than those who had non-identical ST isolates (P = 0.041). CONCLUSION: In our study, ST17 VREF was risk factors of subsequent bacteremia and the strain that showed strong concordance between rectal and blood isolates. Further study is needed to improve clinical outcome of patients carrying VREF using genotype data of rectal VREF isolates. DISCLOSURES: All authors: No reported disclosures. Oxford University Press 2018-11-26 /pmc/articles/PMC6255637/ http://dx.doi.org/10.1093/ofid/ofy210.656 Text en © The Author(s) 2018. Published by Oxford University Press on behalf of Infectious Diseases Society of America. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Abstracts
Kim, Si-Ho
Cho, Sun Young
Kim, Hye Mee
Oh, Suhyun
Jang, Sukbin
Mun, Seokjun
Huh, Kyungmin
Kang, Cheol-In
Peck, Kyong Ran
Chung, Doo Ryun
649. The Clinical Significance of Sequence Type 17 of Vancomycin-Resistant Enterococcus faecium
title 649. The Clinical Significance of Sequence Type 17 of Vancomycin-Resistant Enterococcus faecium
title_full 649. The Clinical Significance of Sequence Type 17 of Vancomycin-Resistant Enterococcus faecium
title_fullStr 649. The Clinical Significance of Sequence Type 17 of Vancomycin-Resistant Enterococcus faecium
title_full_unstemmed 649. The Clinical Significance of Sequence Type 17 of Vancomycin-Resistant Enterococcus faecium
title_short 649. The Clinical Significance of Sequence Type 17 of Vancomycin-Resistant Enterococcus faecium
title_sort 649. the clinical significance of sequence type 17 of vancomycin-resistant enterococcus faecium
topic Abstracts
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6255637/
http://dx.doi.org/10.1093/ofid/ofy210.656
work_keys_str_mv AT kimsiho 649theclinicalsignificanceofsequencetype17ofvancomycinresistantenterococcusfaecium
AT chosunyoung 649theclinicalsignificanceofsequencetype17ofvancomycinresistantenterococcusfaecium
AT kimhyemee 649theclinicalsignificanceofsequencetype17ofvancomycinresistantenterococcusfaecium
AT ohsuhyun 649theclinicalsignificanceofsequencetype17ofvancomycinresistantenterococcusfaecium
AT jangsukbin 649theclinicalsignificanceofsequencetype17ofvancomycinresistantenterococcusfaecium
AT munseokjun 649theclinicalsignificanceofsequencetype17ofvancomycinresistantenterococcusfaecium
AT huhkyungmin 649theclinicalsignificanceofsequencetype17ofvancomycinresistantenterococcusfaecium
AT kangcheolin 649theclinicalsignificanceofsequencetype17ofvancomycinresistantenterococcusfaecium
AT peckkyongran 649theclinicalsignificanceofsequencetype17ofvancomycinresistantenterococcusfaecium
AT chungdooryun 649theclinicalsignificanceofsequencetype17ofvancomycinresistantenterococcusfaecium